Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
NAFTIDROFURYL OXALATE
Merck Serono Limited
C04AX21
NAFTIDROFURYL OXALATE
100 Milligram
Capsule
Product subject to prescription which may be renewed (B)
Other peripheral vasodilators
Authorised
1995-04-01
2 PACKAGE LEAFLET: INFORMATION FOR THE USER PRAXILENE 100 MG CAPSULES Naftidrofuryl hydrogen oxalate The name of your medicine is Praxilene 100 mg capsules, which will be referred to as Praxilene throughout this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Praxilene is and what it is used for 2. What you need to know before you take Praxilene 3. How to take Praxilene 4. Possible side effects 5. How to store Praxilene 6. Contents of the pack and other information 1. WHAT PRAXILENE IS AND WHAT IT IS USED FOR Praxilene belongs to a group of medicines known as ‘metabolic activators’. These are used to treat different types of blood circulation problems. Praxilene allows your body to make better use of the oxygen in your blood. Praxilene is used to treat peripheral vascular disorders (blood circulation problems outside the brain and heart). Praxilene is used to treat the following symptoms of these disorders: • cramp-like pains, usually in your calves when you walk (intermittent claudication) • cramps in your legs at n Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Praxilene 100 mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 100 mg naftidrofuryl hydrogen oxalate. For a full list of excipients, see 6.1. 3 PHARMACEUTICAL FORM Capsule, hard (capsule) Pale pink hard gelatin capsules overprinted with "Praxilene Lipha". 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS In the treatment of: Peripheral vascular disease with such symptoms as intermittent claudication and cold extremities. As with all such drugs, Praxilene capsules are not suitable for the treatment of advanced disease symptoms, such as pain at rest. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology: The usual dose is 100-200mg (1-2 capsules) three times a day (t.i.d). Method of Administration: For oral administration. The capsules should be swallowed whole during meals with a sufficient amount of water (minimum of one glass). _Paediatric population_ This drug is not indicated for use in children. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Patients with a history of hyperoxaluria or recurrent calcium-containing kidney stones. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE When Praxilene is used concomitantly with anti-hypertensive drugs, adjustment of dosage of the latter may be necessary. The product should be used with caution in patients with renal or hepatic insufficiency. Cases of liver damage have been reported. In the event of symptoms suggesting liver damage, Praxilene must be discontinued. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 02/07/2015_ _CRN 2164266_ _page number: 1_ In view of the oxalate content of each Read the complete document